Publications by authors named "Ifat Vigiser"

Claim this Profile
I
Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-up.
Hadar Kolb, Yuval Shachaf, Karin Fainberg, Maya Golan, Keren Regev, Ifat Vigiser

J Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter Study.
Lior Fuchs, Adi Wilf-Yarkoni, Hadar Kolb, Ifat Vigiser, Keren Regev

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis.
Philipp Klyscz, Ifat Vigiser, Gilberto Solorza Buenrostro, Seyedamirhosein Motamedi, Carla Johanna Leutloff

Eur J Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term cognitive outcomes in Susac syndrome: A case series.
Yoav Piura, Noa Bregman, Gitit Kavé, Arnon Karni, Hadar Kolb, Ifat Vigiser

J Neuroimmunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World experience with efgartigimod in patients with myasthenia gravis.
Lior Fuchs, Shahar Shelly, Ifat Vigiser, Hadar Kolb, Keren Regev

J Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smartphone-based gait assessment for multiple sclerosis.
Keren Regev, Noa Eren, Ziv Yekutieli, Keren Karlinski, Ashraf Massri, Ifat Vigiser

Mult Scler Relat Disord· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olfactory function in Susac syndrome.
Yoav Piura, Arnon Karni, Hadar Kolb, Ifat Vigiser, Keren Regev

Clin Neurol Neurosurg· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves.
Alon Doron, Yoav Piura, Ifat Vigiser, Hadar Kolb, Keren Regev

J Neurol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
Lior Fuchs, Karin Mausner-Fainberg, Anna Luban, Susanna Eva Asseyer, Maya Golan, Ifat Vigiser

J Neuroimmunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study.
Arnon Karni, Gil Ben Noon, Tamara Shiner, Ifat Vigiser, Hadar Kolb

Sci Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation.
Maya Golan, Avivit Krivitsky, Karin Mausner-Fainberg, Moshe Benhamou, Ifat Vigiser

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The yield of immediate post lung biopsy CT in predicting iatrogenic pneumothorax.
Rafael Y Brzezinski, Ifat Vigiser, Irina Fomin, Lilach Israeli, Shani Shenhar-Tsarfaty

BMC Pulm Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis